Psychological Disorders Flashcards
Categorical approach to mental disorders - is it good?
Categorical approach often not very beneficial in mental disorders – causes, symptoms, genetics, etc are highly overlapping between disorders, and often comorbid, and people might full fill all criteria for one or more disorders, or partly fulfill them.
The paradox of addiction
the pleasure decrease, and risk increase as addiction progresses. – this applies to pretty much all addictions, from alcohol to gambling to gaming.
Antagonist
• Drug that blocks a neurotransmitter
Agonist
• Drug that mimics or increases an effect
A mixed agonist
An agonist for some effects and an antagonist for others, or an agonist at some doses and an antagonist at others.
Drug’s affinity for a receptor
Measure of drug’s tendency to bind to it
• Ranges from strong to weak affinity
Drug’s Efficacy
tendency to activate the receptor
• A drug’s effectiveness and side effects vary from one person to another
• Largely because the abundance of each type of receptor varies between individuals
Predispositions to substance abuse
- People differ in their predisposition to alcohol or drug abuse – some people will try a drug a few times and quit, others will become addicted.
- Certain aspects of brain function and behavior are present from the start in people with a familial disposition to addiction (regardless if they later become addicts or not)
- Not all individuals develop addiction
Genetic Influences on substance abuse
probability of abusing alcohol or other drugs depends on both genetic and environmental influences
parents’ amount of alcohol use correlates with that of both biological and adopted children, although it correlates more strongly with that of the biological children
Children growing up in unstable environments more susceptible to substance abuse (magnified if also having specific gene affecting serotonin synapses)
- Twin studies confirm strong influence of genetics on vulnerability to alcohol/drugs
- Many addiction-linked genes have been identified, each with a small effect
- Genes affect the probability of substance use, but effects vary depending on environment
- Example: People with a gene for producing less acetaldehyde dehydrogenase metabolize acetaldehyde (from alcohol) more slowly
- Those individuals tend to drink less and have fewer problems with alcohol abuse (e.g., China and Japan) tend to have lower degree/amount of alcohol addiction.
Environmental Influences in alchomolism/drug abuse
- Prenatal environment contributes to risk for alcoholism
- Alcoholic mothers during pregnancy increased probability of child becomes alcoholic, regardless of mother’s alcohol consumption when they grow up.
- Childhood environment is critical
- Careful parenting supervision decreases likelihood of developing impulsive behavior that leads to abuse (even if they have genetic predisposition)
- Alcoholics that develop alcohol problems before age 25 tend to have family history and a genetic predisposition and rapid onset of problems (suggesting early onset alcoholism tend to have a large genetic influence, where later onset might be more due to environmental influence, more likely to respond well to treatment)
Behavioral Predictors of Abuse
One’s behavior can be predictor of substance abuse.
- More impulsive, risk taking, sensation seeking, easily bored people had greater chance of becoming addicts
• Research findings
• Sons of alcoholics show less than average intoxication after drinking a moderate amount of alcohol
• Low level of intoxication may influence person to keep drinking
• Probability of developing alcoholism is greater than 60 percent
• Alcohol decreases stress for most people, but more so for sons of alcoholics
• Similar results have been reported for women
• People ”holding their liqour well” is not something to brag about, but something to be worried about. – higher risk of alcoholism
Synaptic Mechanisms and the role of dopamine in substance abuse
- Nearly all abused drugs affect several kinds of receptors (most abused drugs increase activity at dopamine and noepinephrine synapses)
- The effects while the drug is in the brain differ from effects that occur during withdrawal, and effects responsible for cravings
- Efforts to alleviate drug abuse must consider a variety of mechanisms
Dopamine:
• James Olds and Peter Milner (1954)
• Stimulating rat brains: missed target and hit septum causing rats to respond favorably
• Discovered that rats would push a lever to produce electrical self-stimulation of the brain
• Nucleus accumbens
• Central to reinforcing experiences of all types, not just drugs (where cell stimulating behavior happened)
• Location where addictive drugs release dopamine or norepinephrine (direct release with stimulants, or indirect through opiods)
• Can happen e.g. with sexual behavior, gambling, even imagining things.
Stimulant drugs such as cocaine and
amphetamine increase or prolong the release of dopamine in the nucleus accumbens - most other abused drugs do increase dopamine release directly or indirectly. For example, nicotine
stimulates neurons that release dopamine, and opiates
inhibit neurons that inhibit dopamine release.
–> Dopamine acts as a reinforcer (but I think I decreases over time, behavior is less rewarding, and then they have to do it more to get reward)
BUT! researchers have possibly been overemphasizing the role of dopamine (Drugs that block dopamine synapses do not reduce the reward properties of opiate drugs, and they do not decrease use and not direct relationship between dopamine and pleasentness of drugs)
Cravings
people with addictions have trouble breaking any habit, not just a drug habit. - craving can persist long after the behavior has ceased to be rewarding. a similar pattern for people with prefrontal cortex damage: After they have learned a response or a preference, they are slow to update it in response to new information
- Defining feature for addiction = craving!: Insistent search for the activity (addicts can want something without liking it)
- Even after long period of abstinence, cues can trigger a craving
- The brain mechanism of craving differs from the response to the original activity
- Studies in rats show repeated exposure to an addictive substance alters receptors in nucleus accumbens and other areas to become more responsive to the addictive substance
- And Less responsive to other types of reinforcement
- responses to cues associated with the drug (reminders) become sensitized, attracting greater attention. That increased attention is magnified by the fact that other, competing rewards are less intense than before
- Then, during a period of abstinence, the nucleus accumbens synapses responding to drug cues gradually become more and more sensitive, before later declining partly. – consistent with craving increases during the early stage of abstinence, and slightly declines later
increased response to drug cues has been traced to facilitated glutamate synapses in the nucleus accumbens –> a treatment that desensitizes glutamate synapses
in the nucleus accumbens might reduce cravings for certain drugs.
• Exposure to drugs can disrupt activity in PFC, responsible for restraining impulses = one of biological reasons for cravings and seeking behaviors.
• Tolerance
- Decrease in effect as an addiction develops
- Drug tolerance is learned, to a large extent
- Can be weakened through extinction procedures
• Withdrawal
- Withdrawal
- Body’s reaction to absence of the drug
- One hypothesis is that addictive behavior is an attempt to avoid withdrawal symptoms – but counter evidence! Cocaine addictive but little withdrawal, gambling addictive but no substance withdrawn.
- Modified hypothesis: person with an addiction may use the substance to cope with (di)stress
- Receiving a drug during withdrawal, can create cravings during other types of stressful experience
Treatments for substance use disorders - overview
- Some addicts able to decrease use or quit on their own
- Alcoholics or Narcotics Anonymous (or similar group) (groups that individuals use)
- Cognitive-behavioral therapy (allows for controlling patterns of thinking, attitudes, beliefs, around reactions like drug seeking)
- Contingency management includes rewards for remaining drug-free
- Medication—not as common, but some options are available
Medications to Combat Alcohol Abuse
- Antabuse (disulfiram)
- Makes it harder to metabolize acedylhyde (or what it was called) = Results in sickness after drinking
- Taking a nausea-inducing drug after drinking, to associate the two—learned aversion
- Approach has not become popular (placebo has similar effects, but EXPECTATION of getting sick might make them abstain when on placebo, could explain it)
- Someone who takes an Antabuse pill and then drinks alcohol anyway becomes ill, and in most cases quits taking Antabuse instead of quitting alcohol.
- Naloxone (Narcan) and naltrexone
- Block opiate receptors and decrease pleasure from alcohol
- Drug effectiveness varies with user’s motivation to quit
Medications to Combat Opiate Abuse
• Naloxone (Narcan)
• Opiate antagonist - reverse the effects of an opioid overdose
• Can restore breathing patterns (obstructed in overdose) – you can also do this to unconscious persons
• But will not fix overdoses of other drugs.
• Does not fix addiction, but can save against death (by overdose)
• Methadone as a safer alternative to heroin/morphine/opiates (used to reduce withdrawal ad prevent high from heroin or morphine)
• Similar to heroin and morphine
• Activates same brain receptors and produces same effects
• Can be taken orally, absorbs slowly, and leaves the brain slowly
• “Rush” and withdrawal both reduced.
• Buprenorphine and LAAM
• Similar to methadone
LAAM has the advantage of producing a long-lasting effect
so that the person visits a clinic three times a week instead of
daily. People using any of these drugs live longer and healthier,
on average, than heroin or morphine users, and they are far
more likely to hold a job
All of these drugs don’t end addiction, but can satisfy cravings in a less dangerous way
Major Depressive Disorder and Major depression symptoms
Symptoms:
• Person feels sad and helpless most of the day every day for long periods of time
• Person does not enjoy anything and cannot imagine enjoying anything
• Fatigue, feelings of worthlessness, or contemplation of suicide
• Trouble sleeping
• Cognitive problems: low motivation, impaired memory, concentration problems, and impaired sense of smell
• Cannot imagine being happy
• Their nucleus accumbens becomes less responsive to reward
- Absence of happiness is a more reliable symptom than increased sadness (MDD often decreased response to happy/rewarding stimuli, but normal reaction to sad stimuli)
- More common in women during the reproductive era - about equal before puberty and after menopause (reason unknown)
- Affects five-six percent of adults with a given year
- 10 percent lifetime prevalence
- Some people suffer long-term depression
- More common to have periodic episodes of depression (separated by normal moods – later episodes are more frequent, and the more episodes you have, the greater the risk of getting another one)
Genetics in depression / mood disorders
• Depression has a moderate degree of heritability
• No one gene has been identified as clearly linked to depression (the effect of a gene varies within the environment)
• People with early-onset depression (before age 30) more likely to have relatives with depression as well as relatives with anxiety disorders, neuroticism, ADD, OCD, IBS, and migraine headaches - Early-onset depression also tends to be more severe, more long-lasting, and more associated with suicidal tendencies
• Late onset depression (after age 45) linked to relatives with circulatory problems
Another reason why it is hard to find a gene linked to depression is that when we talk about depression, we may be combining separate syndromes.
- Hypothesis: the effect of a gene varies with the environment (especially the serotonin transporter)
- Evidence:
- Young adults with the short form of the serotonin transporter gene who experienced stressful experiences had a major increase in probability of developing depression.
- Long-form of gene less susceptible to stressful events; one long and one short-moderate risk
- Short-form may increase depressive reaction to stressful events (confirmed by meta analysis, but some results have been divergent)—especially childhood stress
Abnormalities of Hemispheric Dominance in Depression
- Brain activity associated with depression
- Decreased activity in the left prefrontal cortex
- Increased activity in the right prefrontal cortex
- Imbalance stable over the years, despite symptom changes
- It probably represents a predisposition to depression rather than a reaction to it.
- = imbalance in hemispheric dominance for MDD/depression
- People with depression tend to gaze to the left when asked to do a verbal task
- Most people gaze to the right
Antidepressant Drugs - overall
- Many drugs used to treat psychiatric disorders discovered by accident
- Categories of antidepressant drugs
- Tricyclics
- Selective serotonin reuptake inhibitors (SSRIs)
- Monoamine oxidase inhibitors (MAOIs)
- Atypical antidepressants
Presynaptic neuron, when we get it activated and sends down AP, NTs released from vesicles to synaptic cleft, received by postsynaptic receptors, act on post synaptic neuron – when antidepressants do: tricyclics prevent presynaptic from reabsorbing NTs, so they remain in cleft for longer time. SSRI’s do the same, but specific to serotonin. SNRIs block reuptake for serotonin and norepinephrine. MAOIs block MAO from metabolizing catecholamines and serotonin.
Many patients now take two or more drugs with different modes of action, although the effectiveness of this approach is uncertain (mentioned for SNRIs, not sure if applies to all meds)
Although antidepressants vary in which neurotransmitter(s) they target—serotonin, dopamine, norepinephrine, or some combination—all appear to be nearly equal in their effectiveness
It is not possible to predict
which drug will work best for a given patient, so it is strictly a trial-and-error process. Switching to a different type of drug (SSRI versus tricyclic, for example) is no more likely to be helpful than switching to a drug of the same type. Most patients eventually show a favorable response to one of the drugs – but can we know if it was an effect of the drug, or just general recovery (which usually happens within a few months)? – we odn’t know, research fails to include adequate control groups.